Results 161 to 170 of about 1,536,733 (206)

Angelman Syndrome: Consensus for Diagnostic Criteria

open access: yesAmerican Journal of Medical Genetics, Part A, 1995
The Scientific and Research Advisory Committee of the Angelman Syndrome Foundation recently solicited input from scientists involved in the study of Angelman syndrome to establish consensus about the clinical pro- file and diagnostic criteria of Angelman
Daniel J Driscoll   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Epilepsy in Angelman’s Syndrome

Neuroscience and Behavioral Physiology, 2022
Angelman's syndrome (AS) is accompanied by specific changes in the EEG and genetically determined epilepsy. To analyze the neurological status, changes on EEG, MRI, the course of epilepsy in patients with Angelman syndrome (observed at the Svt. uca`s Institute of Child Neurology and Epilepsy).47 patients with a genetically verified diagnosis of AS ...
M.Yu. Bobylova   +4 more
openaire   +2 more sources

Angelman syndrome

Current Problems in Pediatrics, 1995
The Angelman syndrome is a neurological disorder characterized by constant features: severe mental retardation, easily provoked laughter, ataxia, absent speech, seizures. Most cases are sporadic but familial cases have been reported. About 60 to 70% of cases are due to an interstitial deletion on the maternally inherited chromosome 15 in the region q11-
C A, Williams   +6 more
openaire   +4 more sources

Angelman Syndrome

2011
info:eu-repo/semantics ...
Dan, Bernard, Pelc, Karine
  +5 more sources

Myoclonus in Angelman syndrome

Epilepsy & Behavior, 2018
Angelman syndrome (AS) is a neurogenetic imprinting disorder caused by loss of the maternally inherited Ube3a gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Myoclonic seizures are often the first seizure type to appear, and myoclonic status, associated with developmental ...
Sarah F, Pollack   +4 more
openaire   +2 more sources

Anaesthesia for Angelman syndrome

Anaesthesia, 2008
Summary We describe the administration of anaesthesia to a patient with Angelman syndrome, which is characterised by an abnormality of chromosome 15, where a subunit of the GABA receptor is coded. This has far‐reaching anaesthetic implications as many drugs used in anaesthesia are thought to act via GABA receptors.
K. R. Ramanathan   +2 more
openaire   +5 more sources

Hypopigmentation in Angelman syndrome

American Journal of Medical Genetics, 1993
AbstractChromosome region 15q is thought to contain one or more genes that are important for melanin pigment synthesis in the hair, skin, and eyes. Hypopigmentation has been identified in the Prader‐Willi (PWS) and Angelman (AS) syndromes. We have examined 6 individuals with AS to further characterize the pigment pattern in this condition.
R A, King   +3 more
openaire   +2 more sources

Angelman Syndrome Revisited

The Neurologist, 2007
Angelman syndrome (AS) is characterized by severe mental retardation, epilepsy, absent speech, dysmorphic facial features, and a characteristic behavioral phenotype. It is caused by deficiency of gene expression from maternally derived chromosome 15q11-q13.The authors present the clinical picture of 9 children (median age, 4.9 years; range, 1 to 10 ...
Justyna, Paprocka   +5 more
openaire   +2 more sources

Angelman's Syndrome in Infancy

Developmental Medicine & Child Neurology, 1990
SUMMARYThe authors report an 11‐month‐old patient with the clinical features of Angelman Syndrome and a 15q11‐2–12 chromosomal deletion, thus demonstrating that the clinical features may be present in infancy and so allow early diagnosis. The features included pronounced postnatal growth failure, delayed dentition and ossification of growth centers ...
K A, Yamada, J J, Volpe
openaire   +2 more sources

If not Angelman, what is it? a review of Angelman‐like syndromes

American Journal of Medical Genetics Part A, 2014
AbstractAngelman syndrome (AS) is caused by a lack of expression of the maternally inherited UBE3A gene in the brain. However, about 10% of individuals with a clinical diagnosis of AS do not have an identifiable molecular defect. It is likely that most of those individuals have an AS‐like syndrome that is clinically and molecularly distinct from AS ...
Wen-Hann, Tan   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy